Your browser doesn't support javascript.
loading
Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing.
Schrock, Alexa B; Frampton, Garrett M; Herndon, Dana; Greenbowe, Joel R; Wang, Kai; Lipson, Doron; Yelensky, Roman; Chalmers, Zachary R; Chmielecki, Juliann; Elvin, Julia A; Wollner, Mira; Dvir, Addie; -Gutman, Lior Soussan; Bordoni, Rodolfo; Peled, Nir; Braiteh, Fadi; Raez, Luis; Erlich, Rachel; Ou, Sai-Hong Ignatius; Mohamed, Mohamed; Ross, Jeffrey S; Stephens, Philip J; Ali, Siraj M; Miller, Vincent A.
Affiliation
  • Schrock AB; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Frampton GM; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Herndon D; Cone Health, Cancer Center at Wesley Long, Greensboro, North Carolina.
  • Greenbowe JR; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Wang K; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Lipson D; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Yelensky R; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Chalmers ZR; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Chmielecki J; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Elvin JA; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Wollner M; Department of Oncology, Rambam Health Care Campus, Haifa, Israel.
  • Dvir A; Teva Pharmaceuticals, Petah Tikva, Israel.
  • -Gutman LS; Teva Pharmaceuticals, Petah Tikva, Israel.
  • Bordoni R; Georgia Cancer Specialists, Marietta, Georgia.
  • Peled N; Thoracic Cancer Unit, Davidoff Cancer Center, Petach Tiqwa, Israel.
  • Braiteh F; Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada.
  • Raez L; Memorial Healthcare System, Pembroke Pines, Florida.
  • Erlich R; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Ou SH; Chao Comprehensive Cancer Center, Irvine, California.
  • Mohamed M; Cone Health, Cancer Center at Wesley Long, Greensboro, North Carolina.
  • Ross JS; Foundation Medicine Inc., Cambridge, Massachusetts. Albany Medical College, Albany, New York.
  • Stephens PJ; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Ali SM; Foundation Medicine Inc., Cambridge, Massachusetts. Vmiller@foundationmedicine.com sali@foundationmedicine.com.
  • Miller VA; Foundation Medicine Inc., Cambridge, Massachusetts. Vmiller@foundationmedicine.com sali@foundationmedicine.com.
Clin Cancer Res ; 22(13): 3281-5, 2016 07 01.
Article in En | MEDLINE | ID: mdl-26933124
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Gene Expression Profiling / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Gene Expression Profiling / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: